Hycamtin Capsule
Product Images NDC 66758-102

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hycamtin (NDC 66758-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topotecan Hydrochloride Chemical Structure (Hycamtin Spl Graphic 01)

Chemical structure diagram of the active ingredient topotecan, corresponding to the product HYCAMTIN. The diagram shows the molecular arrangement including nitrogen, oxygen, and hydroxyl groups in the topotecan molecule.*

FDA Label Image

Figure 1. Kaplan-meier Curves For Overall Survival In Small Cell Lung Cancer In Study 478 (Hycamtin Spl Graphic 02)

A survival curve comparing cumulative proportion alive over time (months) for two groups: patients receiving best supportive care (BSC) only and patients receiving oral Hycamtin (topotecan) plus BSC. The graph includes number at risk data at multiple time points and shows proportion alive decreasing over 48 months.*

FDA Label Image

Onemgcarton (Onemgcarton)

Packaging label for HYCAMTIN (topotecan) Capsules 1 mg by Sandoz Inc. The label indicates a package size of 10 capsules with directions to see accompanying prescribing information and warnings that HYCAMTIN is cytotoxic. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F) and protection from light. The manufacturer listed is GlaxoSmithKline Manufacturing S.p.A., Italy, with product origin Ireland.*

FDA Label Image

Point25mgcarton (Point25mgcarton)

Packaging label for HYCAMTIN (topotecan) Capsules 0.25 mg oral dosage form by Sandoz Inc. The label indicates a 10 capsule package, with storage instructions to refrigerate between 2°C to 8°C and protect the bottle from light in the original outer carton. The label includes dosage instructions to see accompanying prescribing information and notes that HYCAMTIN is cytotoxic. The labeler and manufacturer details are also printed on the packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.